Physician profile
Faheem Sandhu
NPI 1760487128
$1,509,936.20
in general payments reported to CMS, 2019-2025
52 companies · $213K in 2025
The $213K reported for 2025 was more than what 99% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $195K · 2020: $228K · 2021: $220K · 2022: $263K · 2023: $208K · 2024: $184K · 2025: $213K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $432K · Consulting Fee: $126K · Travel and Lodging: $24K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $13K · Food and Beverage: $8,562.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $432,431.40 |
| Consulting Fee | $126,038.73 |
| Travel and Lodging | $24,082.91 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $13,473.73 |
| Food and Beverage | $8,561.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $437,154.12 | 2019-2025 | Coalition Mis / Mis Ti, Coalition Agx, Quartex |
| Stryker Corporation | $400,934.11 | 2019-2025 | Cascadia Interbody System, Ravine Lateral Access System, Mako |
| Spineart Sa | $112,549.00 | 2019-2024 | |
| Aesculap Implant Systems, LLC | $87,273.38 | 2019-2024 | Activl, Ennovate |
| Innovasis INC | $87,245.27 | 2020-2025 | |
| Kuros Biosciences Ag | $75,806.13 | 2021-2025 | Magnetos |
| Centinel Spine, LLC | $73,423.41 | 2019-2024 | Prodisc C Sk, Prodisc C, Prodisc C Vivo |
| Vb Spine LLC | $61,753.12 | 2025 | Cascadia Interbody System, Everest Spinal System, Aleutian Interbody Systems |
| Integrity Implants INC. Dba Accelus | $21,474.07 | 2023-2024 | Flarehawk |
| Medical Device Business Services, INC. | $19,177.16 | 2022-2025 | Velys, Viper, Trialtis |
| Royal Biologics, INC. | $17,105.16 | 2022-2025 | Fibrinet, Bio-Reign 3d |
| Kuros Biosciences USA, INC | $16,327.52 | 2019-2025 | Magnetos |
| Integrity Implants INC. | $15,510.52 | 2019-2022 | Flarehawk |
| Precision Spine, INC. | $14,201.79 | 2019-2021 | |
| Spine Wave, INC. | $13,281.79 | 2019-2025 | Exceed Biplanar Expandable Interbody System |
Show all 49 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spineart USA INC | $12,514.22 | 2019-2025 | Tryptik Ti |
| Clariance Sas | $10,490.47 | 2019-2025 | Llif 3dti, Idys-Llif 3dti |
| Seaspine Orthopedics Corporation | $6,483.07 | 2021-2022 | |
| Spineology INC. | $6,066.89 | 2020-2024 | Optimesh Expandable Interbody Fusion System |
| Depuy Synthes Products, INC. | $4,024.94 | 2023-2025 | Velys |
| Spineguard, INC. | $3,250.00 | 2021-2024 | |
| 4web, INC. | $3,003.10 | 2021-2024 | Spine Truss System |
| Carlsmed, INC. | $2,267.10 | 2023-2025 | Aprevo |
| Camber Spine Technologies LLC | $1,897.87 | 2019-2021 | |
| Cerapedics INC. | $1,341.04 | 2020-2021 | |
| Nuvasive, INC. | $625.00 | 2023 | Simplify Cervical Artificial Disc |
| Clariance, INC. | $494.87 | 2019 | |
| Medtronic USA, INC. | $482.35 | 2019-2020 | |
| Medtronic, INC. | $411.09 | 2021-2022 | |
| Medicrea USA, Corp. | $364.54 | 2019 | |
| Surgalign Spine Technologies, INC. | $354.23 | 2020-2022 | |
| Acuity Surgical Devices, LLC | $328.01 | 2025 | |
| Supreme Orthopedic Systems, LLC | $323.12 | 2024-2025 | |
| Si-Bone, INC. | $288.14 | 2021-2023 | |
| Baxter Healthcare | $266.75 | 2023-2025 | Floseal |
| Gs Solutions, INC. | $263.73 | 2019-2023 | |
| Arthrex, INC. | $184.95 | 2024 | |
| Spinal Simplicity, LLC | $166.65 | 2019 | |
| Zimvie INC. | $150.95 | 2022 | |
| Precision Medical Products INC. | $137.06 | 2024 | Xstim Spinal Fusion Stimulator |
| Neo Spine USA, INC. | $126.77 | 2020 | |
| Providence Medical Technology, INC. | $100.12 | 2019-2021 | |
| Orthofix Medical, INC. | $84.17 | 2019-2022 | |
| Nevro Corp. | $82.17 | 2020 | |
| Native Surgical, LLC | $49.40 | 2025 | |
| Theragen, INC. | $32.55 | 2024-2025 | Actastim-S |
| Vertos Medical, INC. | $25.42 | 2023 | Mild Device Kit |
| Arteriocyte Medical Systems, INC. | $23.12 | 2024 | Magellan |
| Intrinsic Therapeutics | $15.79 | 2022 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$35,310.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
$102,203.06 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Faheem Sandhu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.